These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M. Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024 [Abstract] [Full Text] [Related]
9. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Tung RH, Camargo CA, Krauser D, Anwaruddin S, Baggish A, Chen A, Januzzi JL. Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921 [Abstract] [Full Text] [Related]
10. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants. Baptista MJ, Rocha G, Clemente F, Azevedo LF, Tibboel D, Leite-Moreira AF, Guimarães H, Areias JC, Correia-Pinto J. Neonatology; 2008 Jul; 94(1):22-30. PubMed ID: 18160811 [Abstract] [Full Text] [Related]
12. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E. Cardiol J; 2009 Jul; 16(1):43-9. PubMed ID: 19130415 [Abstract] [Full Text] [Related]
13. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563 [Abstract] [Full Text] [Related]
14. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure. Piechota WN, Piechota WT, Bejm J, Wierzbowski R, Michałkiewicz D. Adv Med Sci; 2006 Nov 13; 51():164-7. PubMed ID: 17357300 [Abstract] [Full Text] [Related]
15. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG. Eur Heart J; 2006 Jun 13; 27(12):1485-94. PubMed ID: 16682379 [Abstract] [Full Text] [Related]
18. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V, FINNSEPSIS Study Group. Crit Care Med; 2007 May 13; 35(5):1277-83. PubMed ID: 17414731 [Abstract] [Full Text] [Related]
20. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization. Sir JJ, Chung WY, Hwang SJ, Kang HJ, Cho YS, Koo BK, Chae IH, Choi DJ, Kim HS, Sohn DW, Kim CH, Oh BH, Park YB, Choi YS. Int J Cardiol; 2008 Jun 06; 126(3):322-32. PubMed ID: 17544525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]